Evidence map›Paper›PMID 29687215›Full record

ArticleJournal of neurology2018

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

Noelle E Carlozzi, Nicholas R Boileau, Joel S Perlmutter, Kelvin L Chou, Julie C Stout, Jane S Paulsen, Michael K McCormack, David Cella, Martha A Nance, Jin-Shei Lai and 1 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 2 countries.

Noelle E CarlozziDepartment of Physical Medicine and Rehabilitation, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building NCRC B14, Room G216, Ann Arbor, MI, 48109-2800, USA. carlozzi@med.umich.edu.
Nicholas R BoileauDepartment of Physical Medicine and Rehabilitation, University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building NCRC B14, Room G216, Ann Arbor, MI, 48109-2800, USA.
Joel S PerlmutterNeurology, Radiology, Neuroscience, Physical Therapy and Occupational Therapy, Washington University in St. Louis, St. Louis, USA.
Kelvin L ChouDepartment of Neurology, University of Michigan, Ann Arbor, USA.
Julie C StoutSchool of Psychological Sciences, Monash University, Clayton, VIC, Australia.
Jane S PaulsenDepartment of Psychiatry, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA.
Michael K McCormackDepartment of Psychiatry, Rutgers-RWJMS, Piscataway, NJ, USA.
David CellaDepartment of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA.
Martha A NanceStruthers Parkinson's Center, Golden Valley, MN, USA.
Jin-Shei LaiDepartment of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Evanston, IL, USA.
Praveen DayaluDepartment of Neurology, University of Michigan, Ann Arbor, USA.
University of Michigan–Ann Arbor · USNorthwestern University · USHennepin County Medical Center · USMonash University · AURowan University · USUniversity of Iowa · USWashington University in St. Louis · US

Funding

Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
NEUROBIOLOGICAL PREDICTORS OF HUNTINGTON'S DISEASER01NS040068 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S · 2001 to 2013
$48.5M
Institutional Career Development CoreKL2TR002241 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ELLINGROD, VICKI L · 2017 to 2021
$6.9M
Validation of the HD-HRQOL (Huntington disease quality of life measure)R01NS077946 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARLOZZI, NOELLE E. · 2012 to 2016
$3.2M
Michigan Institute for Clinical and Health Research (MICHR) (KL2)KL2RR024987 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$2.8M
Michigan Institute for Clinical and Health Research (MCHR)KL2TR000434 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$1.7M
Statistical disease modeling and clinimetrics to prepare for preventive trials in huntington diseaseR01NS103475 · NINDS · UNIVERSITY OF IOWA · PI PAULSEN, JANE S, ZHANG, YING · 2017 to 2018
$1.2M
National Center for Advancing Translational Sciences UL1TR000433National Institute of Neurological Disorders and Stroke R01NS040068National Institute of Neurological Disorders and Stroke R01NS077946National Institutes of Health Center for Inherited Disease ResearchNCATS NIH HHS KL2 TR000434NCATS NIH HHS KL2 TR002241NCATS NIH HHS UL1 TR000433NCRR NIH HHS KL2 RR024987NINDS NIH HHS R01 NS040068NINDS NIH HHS R01 NS077946NINDS NIH HHS R01 NS103475
6 · The paper itself

Abstract

backgroundClinician-rated measures of functioning are often used as primary endpoints in clinical trials and other behavioral research in Huntington disease. As study costs for clinician-rated assessments are not always feasible, there is a question of whether patient self-report of commonly used clinician-rated measures may serve as acceptable alternatives in low risk behavioral trials.

aimThe purpose of this paper was to determine the level of agreement between self-report and clinician-ratings of commonly used functional assessment measures in Huntington disease.

design486 participants with premanifest or manifest Huntington disease were examined. Total Functional Capacity, Functional Assessment, and Independence Scale assessments from the Unified Huntington Disease Rating scale were completed by clinicians; a self-report version was also completed by individuals with Huntington disease. Cronbach's α was used to examine internal consistency, one-way analysis of variance was used to examine group differences, and paired t tests, kappa agreement coefficients, and intra-class correlations were calculated to determine agreement between raters.

resultsInternal consistency for self-reported ratings of functional capacity and ability were good. There were significant differences between those with premanifest, early-, and late-stage disease; those with later-stage disease reported less ability and independence than the other clinical groups. Although self-report ratings were not a perfect match with associated clinician-rated measures, differences were small. Cutoffs for achieving specified levels of agreement are provided.

conclusionsDepending on the acceptable margin of error in a study, self-reported administration of these functional assessments may be appropriate when clinician-related assessments are not feasible.

Indexed as

Patient Reported Outcome MeasuresPhysiciansActivities of Daily LivingAdultAnalysis of VarianceDiagnostic Self EvaluationDisease ProgressionFemaleHumansHuntington DiseaseMaleMiddle AgedProdromal SymptomsSelf ReportSeverity of Illness IndexClinician-ratingsFunctioningHuntington diseaseSelf-report ratings

Identifiers

PMID29687215
PMCPMC5992091
OpenAlexW2803087852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.